Humanitarian Device Exemption

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

APPROVED_FOR_MARKETING

Study Classification

EXPANDED_ACCESS

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to allow patients to undergo deep brain stimulation (DBS) surgery for the treatment of dystonia. This is NOT a research study, but rather, a requirement by the FDA for humanitarian use of the deep brain stimulator device in the treatment of this rare disorder. Use of DBS for dystonia is approved for humanitarian use by the FDA in the treatment of chronic, intractable (drug refractory) dystonia, including generalized and segmental dystonia, hemidystonia, and cervical dystonia (torticollis) in patients 7 years or older. Thus, this proposal request authorization by the IRB to allow patients at VUMC to access this HUD therapy.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Deep Brain Stimulation Surgery for Movement Disorders

NCT01581580

Parkinson's Disease Essential Tremor Dystonia

RECRUITING NA

Evoked Potential Recording During DBS Surgery

NCT05392569

Movement Disorders in Children

COMPLETED

Multi-Target Pallidal and Thalamic Deep Brain Stimulation for Hemi-Dystonia

NCT02982304

Dystonia Dystonia, Secondary

UNKNOWN PHASE1

Deep Brain Stimulation Surgery for Focal Hand Dystonia

NCT02911103

Dystonia Focal Dystonia Musician's Dystonia

ACTIVE_NOT_RECRUITING PHASE1/PHASE2

Deep Brain Stimulation for Laryngeal Dystonia: From Mechanism to Optimal Application

NCT05506085

Laryngeal Dystonia Adductor Spastic Dysphonia of Dystonia

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of this IRB approved study is to allow patients to undergo deep brain stimulation (DBS) surgery for the treatment of dystonia. This is NOT a research study, but rather, a requirement by the FDA for humanitarian use of the deep brain stimulator device in the treatment of this rare disorder. Use of DBS for dystonia is approved for humanitarian use by the FDA in the treatment of chronic, intractable (drug refractory) dystonia, including generalized and segmental dystonia, hemidystonia, and cervical dystonia (torticollis) in patients 7 years or older. Thus, this proposal request authorization by the IRB to allow patients at VUMC to access this HUD therapy.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dystonia

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Medtronic Activa Gpi

Activa Therapy, Gpi

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

DBS Gpi Activa Therapy

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients whose ages are in the range of 7 and 99 years old
* Patients who are diagnosed with chronic, intractable (drug refractory)primary dystonia, including generalized and or segmental dystonia, hemidystonia, and cervical dystonia (torticollis)as determined by a neurologist or neurosurgeon.
* Patients who have failed appropriate medical therapy as determined by the SMD conference

Exclusion Criteria

* Patients younger than 7 years old
* Patients who are at significant surgical risk as determined by the neurosurgeon and/or anesthesiologist.
* Patients who have not had an adequate trial of medical or non-surgical therapy as determined by the SMD conference.
* Patients not deemed good candidates by the SMD conference group.

Minimum Eligible Age

7 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No